Strategic Planning, Inc. Bristol Myers Squibb CO Transaction History
Strategic Planning, Inc.
- $177 Billion
- Q1 2025
A detailed history of Strategic Planning, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Strategic Planning, Inc. holds 75,458 shares of BMY stock, worth $3.27 Million. This represents 2.6% of its overall portfolio holdings.
Number of Shares
75,458Holding current value
$3.27 Million% of portfolio
2.6%Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,661Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.3M-
Vanguard Group Inc Valley Forge, PA195MShares$8.46 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$6.88 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.69 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.11 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.07 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $92.3B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...